NO20065923L - Doseringsform for avlevering av multiple legemiddelformer - Google Patents
Doseringsform for avlevering av multiple legemiddelformerInfo
- Publication number
- NO20065923L NO20065923L NO20065923A NO20065923A NO20065923L NO 20065923 L NO20065923 L NO 20065923L NO 20065923 A NO20065923 A NO 20065923A NO 20065923 A NO20065923 A NO 20065923A NO 20065923 L NO20065923 L NO 20065923L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- delivery
- dosage form
- multiple drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 239000002552 dosage form Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 150000003839 salts Chemical group 0.000 abstract 3
- 210000001072 colon Anatomy 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 230000001360 synchronised effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57331204P | 2004-05-21 | 2004-05-21 | |
| PCT/US2005/017678 WO2005112896A2 (en) | 2004-05-21 | 2005-05-20 | Dosage form for delivery of multiple drug forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065923L true NO20065923L (no) | 2007-02-13 |
Family
ID=35159875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065923A NO20065923L (no) | 2004-05-21 | 2006-12-20 | Doseringsform for avlevering av multiple legemiddelformer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050260264A1 (pt) |
| EP (1) | EP1750678A2 (pt) |
| JP (1) | JP2008506788A (pt) |
| KR (1) | KR20070013316A (pt) |
| CN (1) | CN1960709A (pt) |
| AU (1) | AU2005244966A1 (pt) |
| BR (1) | BRPI0510034A (pt) |
| CA (1) | CA2565253A1 (pt) |
| IL (1) | IL179456A0 (pt) |
| MX (1) | MXPA06013397A (pt) |
| NO (1) | NO20065923L (pt) |
| WO (1) | WO2005112896A2 (pt) |
| ZA (1) | ZA200610770B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE482695T1 (de) | 2002-12-13 | 2010-10-15 | Durect Corp | Orale darreichungsform mit flüssigen hochviskosen trägersystemen |
| ES2285233T3 (es) | 2002-12-20 | 2007-11-16 | Niconovum Ab | Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable. |
| US20050287214A1 (en) * | 2004-06-28 | 2005-12-29 | Ayer Atul D | Squeeze controlled oral dosage form |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
| US8637080B2 (en) * | 2007-06-28 | 2014-01-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Rupturing controlled release device comprising a subcoat |
| CA2707969C (en) | 2007-12-06 | 2017-04-18 | Pain Therapeutics, Inc. | Micronized opioid compositions, formulations and dosage forms and methods of making same |
| JP2011506319A (ja) | 2007-12-06 | 2011-03-03 | デュレクト コーポレーション | 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法 |
| US8833378B2 (en) * | 2008-09-17 | 2014-09-16 | Niconovum Ab | Process for preparing snuff composition |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| US20120128730A1 (en) * | 2010-11-23 | 2012-05-24 | Nipun Davar | Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron |
| AU2014233453A1 (en) | 2013-03-15 | 2015-10-01 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
| US10716761B2 (en) | 2017-07-24 | 2020-07-21 | Alcresta Therapeutics, Inc. | Ingestible medical delivery devices |
| JP2019026726A (ja) * | 2017-07-28 | 2019-02-21 | 富士ゼロックス株式会社 | 樹脂組成物及び樹脂成形体 |
| US12161146B2 (en) | 2020-02-18 | 2024-12-10 | Intrepid Brands Llc | Synthetic fiber oral flavored product |
| WO2023205692A1 (en) * | 2022-04-19 | 2023-10-26 | Intrepid Brands, LLC | Liquid formulations for oral flavored product |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
| US5922352A (en) * | 1997-01-31 | 1999-07-13 | Andrx Pharmaceuticals, Inc. | Once daily calcium channel blocker tablet having a delayed release core |
| US6419954B1 (en) * | 2000-05-19 | 2002-07-16 | Yamanouchi Pharmaceutical Co., Ltd. | Tablets and methods for modified release of hydrophilic and other active agents |
| AR039744A1 (es) * | 2002-06-26 | 2005-03-09 | Alza Corp | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada |
| NZ537543A (en) * | 2002-07-29 | 2007-08-31 | Alza Corp | Formulations and high dose osmotic dosage forms for controlled delivery of topiramate |
-
2005
- 2005-05-20 BR BRPI0510034-8A patent/BRPI0510034A/pt not_active Application Discontinuation
- 2005-05-20 CA CA002565253A patent/CA2565253A1/en not_active Abandoned
- 2005-05-20 JP JP2007527463A patent/JP2008506788A/ja active Pending
- 2005-05-20 MX MXPA06013397A patent/MXPA06013397A/es not_active Application Discontinuation
- 2005-05-20 CN CNA2005800163243A patent/CN1960709A/zh active Pending
- 2005-05-20 EP EP05759174A patent/EP1750678A2/en not_active Withdrawn
- 2005-05-20 WO PCT/US2005/017678 patent/WO2005112896A2/en not_active Ceased
- 2005-05-20 AU AU2005244966A patent/AU2005244966A1/en not_active Abandoned
- 2005-05-20 US US11/133,769 patent/US20050260264A1/en not_active Abandoned
- 2005-05-20 KR KR1020067025085A patent/KR20070013316A/ko not_active Withdrawn
-
2006
- 2006-11-21 IL IL179456A patent/IL179456A0/en unknown
- 2006-12-20 NO NO20065923A patent/NO20065923L/no unknown
- 2006-12-20 ZA ZA200610770A patent/ZA200610770B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005112896A3 (en) | 2006-05-18 |
| IL179456A0 (en) | 2007-05-15 |
| CN1960709A (zh) | 2007-05-09 |
| BRPI0510034A (pt) | 2007-10-02 |
| CA2565253A1 (en) | 2005-12-01 |
| MXPA06013397A (es) | 2007-01-23 |
| JP2008506788A (ja) | 2008-03-06 |
| US20050260264A1 (en) | 2005-11-24 |
| ZA200610770B (en) | 2008-08-27 |
| EP1750678A2 (en) | 2007-02-14 |
| AU2005244966A1 (en) | 2005-12-01 |
| WO2005112896A2 (en) | 2005-12-01 |
| KR20070013316A (ko) | 2007-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065923L (no) | Doseringsform for avlevering av multiple legemiddelformer | |
| MX2015011896A (es) | Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia. | |
| NO20090593L (no) | Modulatorer av farmakokinetikkegenskaper til terapeutika | |
| DK2114383T3 (da) | Små-volumen orale transmukosale doseringsformer indeholdende sufentanil til behandling af smerte | |
| JP2007522094A5 (pt) | ||
| WO2008146178A3 (en) | A novel tablet dosage form | |
| NO20050835L (no) | Varmsmelte TTS for administrasjon av rotigotin | |
| NO20073403L (no) | Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1 | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| AR030306A1 (es) | Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento | |
| NO20062713L (no) | 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister | |
| MX337603B (es) | Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion. | |
| DK1957110T3 (da) | Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed | |
| TW200738228A (en) | Neramexane modified release matrix tablet | |
| CY1111878T1 (el) | Φαρμακευτικο σκευασμα για τη θεραπεια του ανωτερoy πεπτικου σωληνα | |
| EA200701324A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
| EP4473987A4 (en) | Device for administering a medicinal solution | |
| EP2540294A4 (en) | SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION | |
| AR055099A1 (es) | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol | |
| CY1109939T1 (el) | Εκ του στοματος χορηγουμενη μορφη δοσολογιας για ελεγχομενη αποδεσμευση φαρμακου | |
| WO2007086079A3 (en) | Sustained release dosage form of phenothiazine derivatives containing channelizer | |
| WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin | |
| WO2006108692A3 (en) | Dosage form for oral administration of a vitamin | |
| WO2006040779A3 (en) | Controlled release gastric floating matrix formulation containing imatinib | |
| Kubas et al. | Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators |